An advanced diagnostic package using flow cytometry immunophenotyping on a sample of bone marrow, blood, or lymphoid tissue. It aims to identify and characterize the phenotype of abnormal cells by measuring the expression of a comprehensive cluster of surface and cellular antigens (CD markers). The package accurately distinguishes between subtypes of acute leukemia (ALL, AML) and chronic leukemia (CLL, CML) and lymphoma, providing important prognostic and therapeutic information.